Olivier Terrier
Overview
Explore the profile of Olivier Terrier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Terrier O, Si-Tahar M, Ducatez M, Chevalier C, Pizzorno A, Le Goffic R, et al.
PLoS Pathog
. 2021 Dec;
17(12):e1010106.
PMID: 34969061
The development of safe and effective vaccines in a record time after the emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a remarkable achievement, partly based on...
12.
Ruffin M, Bigot J, Calmel C, Mercier J, Givelet M, Oliva J, et al.
Front Immunol
. 2021 Dec;
12:714027.
PMID: 34950129
In the coronavirus disease 2019 (COVID-19) health crisis, one major challenge is to identify the susceptibility factors of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in order to adapt the recommendations for...
13.
Chupin C, Pizzorno A, Traversier A, Brun P, Ogonczyk-Makowska D, Padey B, et al.
Vaccines (Basel)
. 2021 Oct;
9(10).
PMID: 34696298
The development of a live-attenuated vaccine (LAV) for the prevention of human metapneumovirus (HMPV) infection is often hampered by the lack of highly efficient and scalable cell-based production systems that...
14.
Ferren M, Favede V, Decimo D, Iampietro M, Lieberman N, Weickert J, et al.
Nat Commun
. 2021 Oct;
12(1):5809.
PMID: 34608167
SARS-CoV-2 has caused a global pandemic of COVID-19 since its emergence in December 2019. The infection causes a severe acute respiratory syndrome and may also spread to central nervous system...
15.
Oliva J, Terrier O
Viruses
. 2021 Sep;
13(9).
PMID: 34578306
Respiratory tract infections constitute a significant public health problem, with a therapeutic arsenal that remains relatively limited and that is threatened by the emergence of antiviral and/or antibiotic resistance. Viral-bacterial...
16.
Terrier O, Slama-Schwok A
Adv Exp Med Biol
. 2021 Jul;
1322:195-218.
PMID: 34258742
Infections by influenza virus constitute a major and recurrent threat for human health. Together with vaccines, antiviral drugs play a key role in the prevention and treatment of influenza virus...
17.
Asarnow D, Wang B, Lee W, Hu Y, Huang C, Faust B, et al.
Cell
. 2021 May;
184(12):3192-3204.e16.
PMID: 33974910
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is initiated by binding of the viral Spike protein to host receptor angiotensin-converting enzyme 2 (ACE2), followed by fusion of viral...
18.
Terrier O, Dilly S, Pizzorno A, Chalupska D, Humpolickova J, Boura E, et al.
Molecules
. 2021 May;
26(9).
PMID: 33946802
There is an urgent need for specific antiviral treatments directed against SARS-CoV-2 to prevent the most severe forms of COVID-19. By drug repurposing, affordable therapeutics could be supplied worldwide in...
19.
Goncalves A, Maisonnasse P, Donati F, Albert M, Behillil S, Contreras V, et al.
PLoS Comput Biol
. 2021 Mar;
17(3):e1008785.
PMID: 33730053
Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and...
20.
Eymieux S, Rouille Y, Terrier O, Seron K, Blanchard E, Rosa-Calatrava M, et al.
Cell Mol Life Sci
. 2021 Jan;
78(7):3565-3576.
PMID: 33449149
Many studies on SARS-CoV-2 have been performed over short-time scale, but few have focused on the ultrastructural characteristics of infected cells. We used TEM to perform kinetic analysis of the...